Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 93573101000001116 | Pembrolizumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 93573201000001111 | Pembrolizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pembrolizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pembrolizumab 50mg powder for solution for infusion vials | Has specific active ingredient | False | Pembrolizumab | Inferred relationship | Existential restriction modifier | |
| Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) | Has specific active ingredient | False | Pembrolizumab | Inferred relationship | Existential restriction modifier | |
| Pembrolizumab 50mg powder for solution for infusion vials 1 vial | Has specific active ingredient | False | Pembrolizumab | Inferred relationship | Existential restriction modifier | |
| Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial | Has specific active ingredient | False | Pembrolizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR